Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambria Africa Regulatory News (CMB)

  • This share is currently suspended. It was suspended at a price of 0.45
  • There is currently no data for CMB

Cambria raises additional Debt Financing

19 Feb 2013 07:00

RNS Number : 1493Y
Cambria Africa PLC
19 February 2013
 



Cambria Africa plc

("Cambria" or the "Company")

 

Cambria raises additional Debt FinancingEntry of Zambian markets by Millchem 

 

·; Cambria has increased its existing debt facility with Consilium Investment Management (1) by $1.5m
·; Financing will be primarily used to fund entry by Cambria’s Millchem investment into the Zambian market as well as refinancing of existing liabilities of the Company

 

Cambria (AIM:CMB) is pleased to announce that it has successfully secured an additional US$ 1.5 million in debt financing from Consilium Investment Management (1) (Consilium) bringing the total facility held with Consilium to US$ 4.5 million.

 

The increased financing now available will be used to fund entry of Cambria's rapidly growing Millchem investment into the Zambian market, refinance existing debt obligations of the Company, as well as for general working capital purposes.

 

Millchem, a wholly owned subsidiary of Cambria, is a value-added chemicals distributor with substantial reach and a leading market position in Zimbabwe. It is the premier distributor in the country of, among others, solvents, metal treatments, and alkyd resins. In a trading update released by Cambria on September 19, 2012, it was announced Millchem had organically grown gross profits year-on-year by 95%.

 

Cambria's Chief Executive, Edzo Wisman, commented: "Besides refinancing existing liabilities of the Company, this new financing facilitates an acceleration of Millchem's entry into the Zambian market. Millchem has increasingly explored opportunities in the region on the back of stellar growth achieved in the Zimbabwean business. After the success of initial sales into Zambia, Cambria will now invest in a more structured presence for Millchem, including a Lusaka office and warehouse. Various existing suppliers, encouraged by Millchem's rapid growth in Zimbabwe, have already offered to extend Millchem's Zimbabwe agencies into Zambia."

 

Cambria's Payserv investment, until recently operating as Paynet Group, established a Lusaka office in December 2012, in anticipation of entering the Zambian market. Partnering with existing players it expects to lead with its Paynet EDI switching technology and make available its other outsourcing products to Zambia's growing financial and business sector.

 

The regional expansion of both these key portfolio companies is in line with Cambria's continued strategy, actively focusing on value creation within our profitable, core investments.

 

Ian Perkins, Cambria's Chair, commented on the increased facility with Consilium: "We continue to appreciate the confidence from our significant shareholder Consilium in the progress made at Cambria, evidenced again with this additional debt financing provided to us."

 

Jonathan Binder, Managing Director of Consilium Investment Management, adds: "We remain excited and impressed with the developments at Cambria and, as already stated in December, we are committed to playing a supportive role in providing debt and equity finance for the company."

 

The facility, as previously disclosed in an RNS 10 December 2012, carries a 15% annualized interest rate and is due for repayment 8 March 2014. As part of the expansion of the debt facility with US$ 1.5m, Consilium has been given a 'general charge' over the Company, while maintaining security directly related to certain properties owned by Cambria, as well as receipt of a warrant instrument (the "Warrant"). The Warrant provides for the issue of 5,000,000 new ordinary shares of £0.0001 each in the capital of the Company at an exercise price of 13p per Share. The Warrant is exercisable in whole or in part by Consilium at any time prior to 15 February 2016.

 

Consilium, through the various funds it manages, is a substantial shareholder of Cambria, and the transaction is therefore deemed a related party transaction for the purpose of the AIM Rules for Companies.

 

With the exception of Ian Perkins, a director nominated by Consilium's investment manager, the Directors, having consulted with WH Ireland, the Company's nominated advisor, consider the terms of the debt facility to be fair and reasonable insofar as its shareholders are concerned.

 

(1) Consilium Investment Management in this restructuring represented the Consilium Corporate Recovery Master Fund and the Consilium Emerging Markets Absolute Return Master Fund

 

About Cambria Africa plc

Cambria Africa plc, quoted on the AIM market of the London Stock Exchange, is a long term, active investment company, building a portfolio of investments primarily in Zimbabwe.

 

Contacts

Cambria Africa plc

www.cambriaafrica.com

Ian Perkins

+44 (0) 7831 674 585

Edzo Wisman

+ 1 (0) 416 358 1910

WH Ireland Limited

www.wh-ireland.co.uk

James Joyce / Nick Field

+44 (0) 20 7220 1666

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODGGUQAPUPWGRR
Date   Source Headline
17th Mar 201512:10 pmRNSCorrections to previous announcements
18th Feb 20151:19 pmRNSAdjournment of General Meeting
17th Feb 20157:30 amRNSSuspension - Cambria Africa Plc
16th Feb 20155:45 pmRNSSubscription Agreement
5th Feb 20157:00 amRNSProposed Delisting and Trading in Shares
23rd Jan 20157:00 amRNSProposed Cancellation of trading on AIM
23rd Oct 20147:00 amRNSTrading update and sale of hotel
19th Sep 20147:00 amRNSHolding(s) in Company
19th Sep 20147:00 amRNSHolding(s) in Company
26th Aug 20147:00 amRNSClosing of Acquisition & Distribution Agreements
14th Jul 20147:00 amRNSFormal claims of c.US$10m lodged against Lonrho
18th Jun 201411:46 amRNSResult of EGM
2nd Jun 20147:00 amRNSNotice of EGM
30th May 201411:00 amRNSInterim Results
27th May 20147:00 amRNSAcquisition of Malawi Chemicals Distributor
23rd May 20147:00 amRNSNew Key Distribution Agreements for Millchem
2nd May 20149:20 amRNSResult of AGM
17th Apr 201410:10 amRNSHolding(s) in Company
17th Apr 201410:10 amRNSHolding(s) in Company
17th Apr 201410:07 amRNSHolding(s) in Company
18th Mar 20147:00 amRNSNotice of AGM
11th Mar 201412:41 pmRNSSecond Close of Placing
3rd Mar 20147:00 amRNSFirst Close of Placing
27th Feb 20147:00 amRNSResults for the full year ending 31 August 2013
19th Feb 20147:13 amRNSIssue of New Shares
20th Jan 20147:00 amRNSTrading Update and Appointment of Joint Broker
23rd Sep 20137:00 amRNSBoard resignation and appointment of Controller
1st Aug 20137:00 amRNSCompletion of the Sale of Celsys Ltd
25th Jul 20137:00 amRNSSale of Investee Company
22nd Jul 20137:00 amRNSUS$ 2.7 million settlement with Lonrho plc
19th Jul 20137:00 amRNSCompletion of US$2 million convertible debt
20th Jun 20135:53 pmRNSHolding(s) in Company
9th May 20137:00 amRNSPlacement of US$2million convertible by subsidiary
1st May 20137:00 amRNSExtension of maturity on debt financing
22nd Apr 201311:27 amRNSResult of AGM
16th Apr 20137:00 amRNSResults for the six months ending 28 February 2013
25th Mar 201310:21 amRNSNotice of AGM
28th Feb 20133:09 pmRNSFinal Results
19th Feb 20137:00 amRNSCambria raises additional Debt Financing
15th Feb 20137:00 amRNSCompletion of sale of FMNA
11th Dec 20127:00 amRNSDirectorate Change
10th Dec 201210:01 amRNSCambria Completes Debt Restructuring
15th Nov 201211:42 amRNSHolding(s) in Company
11th Oct 20128:42 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSCompletion of Placing
1st Oct 20127:00 amRNSIssue of New Shares
21st Sep 20124:45 pmRNSTR1 - Notification of major interest in shares
21st Sep 20124:39 pmRNSTR1 - Notification of major interest in shares
18th Sep 20127:00 amRNSTrading Update
14th Sep 20124:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.